Lexapro (Escitalopram) Tablets

Lexapro is the brand name for escitalopram, a selective serotonin reuptake inhibitor (SSRI) that we offer as oral tablets in 5 mg, 10 mg, and 20 mg strengths. Prescribers use escitalopram to treat major depressive disorder and generalized anxiety disorder, and it remains one of the most widely used antidepressants because of its consistent effectiveness and generally manageable side-effect profile. This article walks through how escitalopram works, what a typical course of treatment involves, its safety considerations, and how our Lexapro tablets relate to generic escitalopram and other antidepressant options, so you can have an informed conversation with your prescriber.

What Is Lexapro?

Lexapro tablets contain escitalopram oxalate, the active, single-enantiomer form of the older antidepressant citalopram. Each film-coated tablet is taken by mouth, and we currently stock the three FDA-approved strengths: 5 mg, 10 mg, and 20 mg. Escitalopram belongs to the SSRI class (ATC code N06AB10), a group of medicines that increase serotonin activity in the brain rather than broadly sedating or stimulating the nervous system. For each strength, we offer packages of 10, 20, 30, 60, 90, 120, 180, 270, or 360 pills, allowing customers to choose between smaller and longer-term supplies.

Understanding Depression and Anxiety

Major depressive disorder involves persistent low mood, loss of interest, sleep and appetite changes, and reduced energy that interfere with daily functioning for two weeks or longer. Generalized anxiety disorder involves excessive, hard-to-control worry accompanied by restlessness, muscle tension, or sleep disturbance most days for six months or more. Both conditions are common and frequently overlap. Depending on symptom severity, patient preference, and previous treatment response, care may involve psychotherapy, medication, or a combination of both. Escitalopram is a first-line pharmacological option in many treatment guidelines because it acts on serotonin pathways involved in mood and anxiety regulation.

How Escitalopram Works

Escitalopram selectively blocks the serotonin transporter on presynaptic neurons, which slows the reabsorption of serotonin released into the synapse. The resulting increase in synaptic serotonin activity is thought to trigger longer-term adaptive changes in postsynaptic receptor sensitivity over several weeks, which is why antidepressant benefit builds gradually rather than appearing immediately. Because escitalopram is the more pharmacologically active enantiomer isolated from citalopram, it achieves substantial serotonin transporter occupancy at relatively low milligram doses. It has minimal activity at noradrenaline and dopamine transporters and low affinity for histamine, cholinergic, or adrenergic receptors, which helps explain its relatively light sedative and anticholinergic burden compared with older antidepressant classes.

Evidence Behind Escitalopram

Escitalopram's approval for major depressive disorder rested on placebo-controlled trials of eight weeks or longer that measured standardized depression scales such as the Montgomery-Åsberg Depression Rating Scale, with escitalopram groups showing significantly greater symptom reduction than placebo. Separate randomized trials in generalized anxiety disorder demonstrated meaningful reductions on the Hamilton Anxiety Rating Scale relative to placebo, supporting its second FDA indication. Comparisons with citalopram generally show broadly similar effectiveness and tolerability, although individual studies have reported modest differences that are not consistent enough to predict which medicine will suit a particular patient. Longer maintenance trials have shown that continuing escitalopram after an acute response reduces relapse risk compared with stopping treatment early.

Trial averages do not guarantee an individual result. Some people respond well to the first SSRI they try, while others need a dose adjustment, a longer trial, or a different medicine. Prescribers typically assess changes in mood, anxiety, sleep, daily functioning, and adverse effects over several appointments rather than judging effectiveness from the first few doses.

Ingredients and Tablet Formulation

Lexapro is supplied as a conventional immediate-release oral tablet. Each strength provides the labeled amount of escitalopram as escitalopram oxalate: 5 mg, 10 mg, or 20 mg of escitalopram. The tablet coating and inactive ingredients help provide a stable solid dosage form but do not create an extended-release effect. Anyone with a known sensitivity to a tablet component should review the current package labeling with a pharmacist or prescriber before use. Generic escitalopram products may use different inactive ingredients while delivering the same active ingredient and labeled strength.

Approved Uses

Escitalopram is approved for major depressive disorder in adults and adolescents 12 years and older, and for generalized anxiety disorder in adults and children as young as 7 years old, always under a prescriber's supervision. Clinicians also prescribe it off-label for related conditions such as panic disorder, social anxiety disorder, and obsessive-compulsive disorder, drawing on the broader SSRI evidence base, though these uses fall outside the specific FDA-approved label.

Strengths, Package Options, and General Dosing

We list Lexapro in 5 mg, 10 mg, and 20 mg tablets, with packages of 10, 20, 30, 60, 90, 120, 180, 270, or 360 pills available for each strength. In general clinical practice, adults typically begin at 10 mg once daily for both depression and generalized anxiety disorder, taken at the same time each day with or without food. A prescriber may increase the dose to the 20 mg maximum after at least one week if symptom response is insufficient. Older adults and people with hepatic impairment are generally prescribed 10 mg once daily. CYP2C19 poor metabolizers may have increased exposure to escitalopram, so their dose, other medicines, and adverse effects may warrant closer clinical review.

Lexapro can be taken in the morning or evening. Morning dosing may be more comfortable if it causes insomnia, while evening dosing may suit someone who experiences drowsiness. Nausea can sometimes be reduced by taking the tablet with food, although food is not required for absorption. If a dose is missed, the patient should follow the instructions provided by the prescriber or Medication Guide and should not double the next dose unless specifically directed.

Early changes in sleep, appetite, or anxiety may appear before the full effect on mood. Meaningful improvement often begins within two to four weeks, but a complete assessment may require six to eight weeks at a therapeutic dose. These figures describe general prescribing patterns rather than an individual regimen, and the exact starting dose, titration pace, and target dose should always follow the plan set by the prescriber who evaluated the patient.

Elimination and Half-Life

Escitalopram has an elimination half-life of roughly 27 to 32 hours in adults with normal liver function, which supports once-daily dosing and means that steady-state blood levels are typically reached after about one week of consistent use. It is metabolized mainly by the liver enzyme CYP2C19, with smaller contributions from CYP3A4 and CYP2D6, and escitalopram and its metabolites are eliminated partly through the kidneys. People who are genetically poor CYP2C19 metabolizers, or who take CYP2C19 inhibitors, can have higher escitalopram exposure and may need closer monitoring. Because of this relatively long half-life, one late or missed dose does not immediately remove the medicine from the body, but stopping it abruptly after regular use can still trigger discontinuation symptoms.

Important Safety Information

Like other antidepressants, Lexapro carries an FDA boxed warning about an increased risk of suicidal thoughts and behaviors in pediatric and young adult patients, particularly during the first weeks of treatment or after a dose change. Anyone taking it, or caring for someone who is, should watch for new or worsening mood changes, agitation, unusual behavior, or thoughts of self-harm and contact a healthcare provider promptly if these appear.

Pregnancy and Breastfeeding

Escitalopram use later in pregnancy, especially in the third trimester, has been associated with neonatal complications such as respiratory distress, feeding difficulty, irritability, and, rarely, persistent pulmonary hypertension of the newborn. Any decision about continuing or adjusting treatment during pregnancy requires individualized guidance rather than abrupt discontinuation. Escitalopram also passes into breast milk, and breastfed infants have occasionally shown excess sleepiness, reduced feeding, or weight loss, so infants of breastfeeding parents taking this medicine should be monitored for those signs.

Children and Adolescents

Pediatric dosing follows narrower age limits than adult dosing, and pediatric patients require closer monitoring for suicidal thinking or behavioral changes, especially soon after starting treatment or changing the dose.

Diabetes and Blood Sugar

SSRIs including escitalopram can occasionally alter blood glucose control, so people with diabetes may need more frequent glucose monitoring and occasional adjustment of insulin or oral diabetes medication after starting or stopping treatment.

Driving and Mental Alertness

Escitalopram can affect judgment, thinking, or coordination in some people, so it is sensible to avoid driving or operating machinery until you know how the medicine affects you personally.

Monitoring During Treatment

Before treatment, prescribers commonly review previous manic or hypomanic episodes because an antidepressant can precipitate mania in someone with bipolar disorder. Follow-up generally covers symptom response, suicidal thinking, sleep, agitation, sexual adverse effects, and adherence. Sodium testing may be appropriate for older adults, people taking diuretics, or anyone who develops confusion, weakness, or seizures. An electrocardiogram or electrolyte testing may be considered when cardiac disease, QT prolongation, interacting medicines, or low potassium or magnesium increases rhythm risk.

Prescription Requirements and Ordering Through Us

Lexapro is a prescription-only medicine in the United States and is available for clinical use with authorization from a licensed healthcare professional. That regulatory classification is separate from our own policy for accepting an order: when you order Lexapro through PocketDrugGuide, we do not require you to upload or submit a prescription before we accept the order itself. We still encourage every customer to confirm with a licensed prescriber that escitalopram is appropriate for their health history and current medications. Since 2018, we have paired that streamlined ordering experience with pharmacist support available 24/7 through email and online chat. Orders are priced and processed in US dollars, with shipping available to US addresses.

Who Should Avoid Escitalopram

Escitalopram is contraindicated in anyone with known hypersensitivity to escitalopram, citalopram, or the tablet's other ingredients. It should not be combined with a monoamine oxidase inhibitor (MAOI) used currently or within the preceding 14 days, or with pimozide, because of serious interaction risks. Treatment involving linezolid or intravenous methylene blue also requires urgent professional review because these agents can have MAOI activity. Escitalopram is approached with caution in people with a personal or family history of QT-interval prolongation, uncorrected electrolyte imbalances, seizure disorders, bipolar disorder, bleeding risks, or conditions that increase the likelihood of low sodium.

Drug and Substance Interactions

Escitalopram interacts with several medicine groups in ways that matter for everyday safety, from other serotonin-raising drugs to medicines that affect heart rhythm or bleeding risk. The table below summarizes five clinically important interaction groups and the precautions they may require.

Combining escitalopram with other serotonergic medicines, including other antidepressants, triptans, tramadol, or St. John's wort, raises the risk of serotonin syndrome, a potentially serious cluster of symptoms involving agitation, rapid heartbeat, muscle rigidity, and fever. NSAIDs, aspirin, and blood thinners taken alongside escitalopram increase bleeding risk because SSRIs also modestly reduce platelet serotonin. Medicines that prolong the QT interval can add to cardiac rhythm risk, while CYP2C19 inhibitors such as omeprazole or fluconazole may increase escitalopram exposure. A prescriber or pharmacist should therefore review prescription medicines, over-the-counter products, and supplements before treatment begins.

Alcohol does not create the same specific metabolic interaction as an MAOI, but it can worsen drowsiness, impaired judgment, depression symptoms, or other central nervous system effects. Patients should ask their prescriber whether alcohol is appropriate for them rather than assuming that a consistent amount is safe during treatment.

Side Effects and When to Get Help

The most common effects reported with escitalopram include nausea, dry mouth, drowsiness or insomnia, increased sweating, decreased appetite, and sexual side effects such as reduced libido or delayed orgasm. These often ease within the first few weeks as the body adjusts, but persistent or troublesome effects should be discussed rather than managed by changing the dose without guidance. Seek prompt medical attention for signs of serotonin syndrome such as high fever, muscle rigidity, or rapid heartbeat; unusual bruising or bleeding; confusion, severe headache, or muscle weakness that could indicate low sodium; a serious allergic reaction with swelling or difficulty breathing; or any new or worsening thoughts of self-harm. In the United States, call 911 or go to the nearest emergency department for emergency symptoms.

Stopping escitalopram suddenly can cause dizziness, irritability, anxiety, headache, sleep disturbance, sweating, nausea, or electric-shock-like sensations. These are discontinuation symptoms rather than evidence that the medicine is addictive. When treatment is no longer needed, prescribers generally reduce the dose gradually and adjust the taper if symptoms emerge.

Overdose and Toxicity

An escitalopram overdose can cause dizziness, vomiting, rapid heartbeat, drowsiness, tremor, and, in more severe cases, seizures, marked QT prolongation, or symptoms of serotonin syndrome. Taking an overdose with alcohol or other medicines may make the outcome less predictable and more dangerous. There is no specific antidote, so treatment relies on supportive care such as airway management and cardiac monitoring; clinicians may consider activated charcoal in an appropriate recent ingestion. Anyone who may have taken more than the prescribed amount, or who supervises a child who has swallowed Lexapro tablets, should contact Poison Control at 1-800-222-1222 or seek emergency care immediately.

Storage

Store Lexapro tablets at 77°F; brief excursions between 59°F and 86°F are permitted. Keep the tablets in a tightly closed container, away from excess moisture and out of reach of children and pets. A medicine take-back location is the preferred disposal option for unused or expired tablets. If one is not readily available, follow the current FDA household-disposal instructions or ask a pharmacist how to dispose of the medicine safely; do not flush it unless the product instructions specifically direct you to do so.

Benefits and Trade-offs

Escitalopram's main practical advantages are its once-daily dosing, a relatively low burden of anticholinergic and sedative side effects compared with older tricyclic antidepressants, and a solid evidence base across both depression and generalized anxiety disorder. It has few clinically significant effects on many liver enzymes, which can simplify some medicine combinations, although important serotonergic, bleeding, cardiac, and CYP2C19-related interactions remain.

The trade-offs include a gradual onset of benefit, a real chance of sexual side effects that some patients find difficult to tolerate, and a need for gradual dose tapering rather than abrupt stopping. Some people experience activation, insomnia, or increased anxiety early in treatment, while others feel tired. Escitalopram is also not an appropriate stand-alone treatment for bipolar depression, where antidepressant use requires a treatment plan that addresses the risk of mania.

Generic Escitalopram and Other Antidepressant Options

Generic escitalopram tablets contain the same active ingredient and are available in the same 5 mg, 10 mg, and 20 mg immediate-release oral strengths as Lexapro. FDA-approved generic products must meet applicable quality and bioequivalence standards and are typically available at a lower price, although tablet appearance and inactive ingredients can differ by manufacturer.

If response to escitalopram is inadequate or its adverse effects are difficult to tolerate, prescribers may consider other SSRIs such as citalopram, sertraline, fluoxetine, or Paxil (paroxetine). These are not interchangeable milligram for milligram: paroxetine tends to have more anticholinergic effects and discontinuation symptoms, fluoxetine has a much longer half-life, and sertraline may cause more gastrointestinal effects in some patients. SNRIs such as venlafaxine or duloxetine affect both serotonin and norepinephrine and have different blood pressure, withdrawal, and pain-related considerations.

For partial response, a prescriber may add an augmenting agent such as Abilify (aripiprazole) rather than switching antidepressants outright. Augmentation introduces a different adverse-effect and monitoring profile, so it is not simply a stronger version of SSRI treatment. For broader information about SSRIs and related treatment choices, visit our AntiDepressants section.